Skip to main content

Series D Therapeutics Companies

Explore 29 therapeutics startups that raised series d funding. Access verified founder contact information and fundraising data.

Total Companies
29
Total Funding
$562.0M
Avg Funding
$140.5M
Cities
4

Export 29 Series D Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Seongnam, South Korea
$21.9M
raised

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

Jan 2026
Series D

Founder Contacts

30,000+ verified contacts

Chicago, United States
$270.0M
raised

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Nov 2022
Series D

Founder Contacts

30,000+ verified contacts

Allschwil, Switzerland
$181.4M
raised

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Nov 2024
Series D

Founder Contacts

30,000+ verified contacts

Antwerpen, Belgium
$88.7M
raised

Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.

Oct 2024
Series D

Founder Contacts

30,000+ verified contacts

Showing 26 to 29 of 29 companies

Ready to Connect with Series D Therapeutics Startups?

Get verified founder emails, funding details, and company data for 29 series d therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked